aTyr Pharma, Inc. (ATYR) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -12.52M | -12.2M | -20.48M | -13.89M | -15.42M | -13.13M | -13.16M | -20.45M | -22.38M | -11.06M | -9.56M | -12.01M |
| Operating CF Margin % | - | - | -10776.84% | - | - | - | - | - | -9523.4% | - | -2707.93% | - |
| Operating CF Growth % | 18.83% | 7.13% | -55.62% | 32.06% | 31.1% | -18.71% | -37.65% | -70.27% | -3693.22% | -6.68% | 22.16% | -31.73% |
| Net Income | -10.79M | -13.96M | -25.75M | -19.53M | -14.88M | -14.97M | -17.26M | -16.31M | -15.49M | -14.76M | -11.34M | -12.34M |
| Depreciation & Amortization | 394K | 394K | 389K | 387K | 383K | -1K | 388K | 383K | 770K | 407K | 993K | 586K |
| Stock-Based Compensation | 1.31M | 0 | 1.31M | 1.3M | 1.18M | 770K | 752K | 727K | 740K | 659K | 664K | 658K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -255K | 833K | -512K | -458K | -523K | -553K | -611K | -735K | -807K | -887K | -979K | -895K |
| Working Capital Changes | -3.17M | 540K | 4.09M | 4.4M | -1.58M | 1.62M | 3.57M | -4.52M | -7.59M | 3.52M | 1.1M | -17K |
| Change in Receivables | 396K | 169K | -544K | 490K | 748K | 95K | -203K | 56K | 454K | -458K | -1.04M | 671K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -3.47M | -536K | 0 | 0 | -4.32M | 825K | 2.24M | -4.18M | -228K | 3.39M | 893K | 0 |
| Cash from Investing | 11.49M | 16.44M | -20.38M | 3.3M | -4.42M | -6.08M | 17.95M | 6.73M | -1.36M | 17.82M | 4.38M | -4.16M |
| Capital Expenditures | -138K | -31K | -37K | -9K | 0 | -25K | -15K | -8K | -17K | -17K | -557K | -2.4M |
| CapEx % of Revenue | - | - | 19.47% | - | - | - | - | - | 7.23% | - | 157.79% | - |
| Acquisitions | 0 | 12K | 0 | 0 | 0 | 7K | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 255K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15K |
| Cash from Financing | -142K | -131K | 29.62M | 17.9M | 18.63M | 18.84M | -105K | 13.4M | 7.73M | 6.03M | 2.68M | 8.02M |
| Debt Issued (Net) | -142K | -139K | -136K | -133K | -131K | -128K | -125K | -123K | -121K | -115K | -108K | -105K |
| Equity Issued (Net) | 0 | 8K | 29.75M | 17.93M | 18.76M | 18.91M | 20K | 13.48M | 7.85M | 6.11M | 2.79M | 8.06M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 98K | 0 | 61K | 0 | 39K | 0 | 40K | 0 | 65K |
| Net Change in Cash | -1.17M | 4.59M | -11.24M | 7.3M | -1.21M | -378K | 4.68M | -321K | -15.74M | 12.76M | -2.53M | -8.15M |
| Free Cash Flow | -12.65M | -12.23M | -20.51M | -13.9M | -15.42M | -13.16M | -13.17M | -20.46M | -22.4M | -11.08M | -10.12M | -14.4M |
| FCF Margin % | - | - | -10796.32% | - | - | - | - | - | -9530.64% | - | -2865.72% | - |
| FCF Growth % | 17.93% | 7.07% | -55.72% | 32.04% | 31.15% | -18.76% | -30.22% | -42.01% | -1119.88% | 3.56% | 20.39% | -57.09% |
| FCF per Share | -0.13 | -0.12 | -0.21 | -0.15 | -0.18 | -0.16 | -0.17 | -0.28 | -0.34 | -0.19 | -0.17 | -0.26 |
| FCF Conversion (FCF/Net Income) | 1.16x | 0.87x | 0.80x | 0.71x | 1.04x | 0.88x | 0.76x | 1.25x | 1.44x | 0.75x | 0.84x | 0.97x |
| Interest Paid | 0 | 0 | 22K | 25K | 28K | 30K | 33K | 0 | 0 | 0 | 0 | 48K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |